OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Proteogenomic characterization of pancreatic ductal adenocarcinoma
Liwei Cao, Chen Huang, Daniel Cui Zhou, et al.
Cell (2021) Vol. 184, Iss. 19, pp. 5031-5052.e26
Open Access | Times Cited: 368
Liwei Cao, Chen Huang, Daniel Cui Zhou, et al.
Cell (2021) Vol. 184, Iss. 19, pp. 5031-5052.e26
Open Access | Times Cited: 368
Showing 1-25 of 368 citing articles:
Tumor Microenvironment in Pancreatic Cancer Pathogenesis and Therapeutic Resistance
Mara H. Sherman, Gregory L. Beatty
Annual Review of Pathology Mechanisms of Disease (2022) Vol. 18, Iss. 1, pp. 123-148
Open Access | Times Cited: 197
Mara H. Sherman, Gregory L. Beatty
Annual Review of Pathology Mechanisms of Disease (2022) Vol. 18, Iss. 1, pp. 123-148
Open Access | Times Cited: 197
Glycoproteomics
Ieva Bagdonaite, Stacy A. Malaker, Daniel A. Polasky, et al.
Nature Reviews Methods Primers (2022) Vol. 2, Iss. 1
Open Access | Times Cited: 153
Ieva Bagdonaite, Stacy A. Malaker, Daniel A. Polasky, et al.
Nature Reviews Methods Primers (2022) Vol. 2, Iss. 1
Open Access | Times Cited: 153
Single-cell RNA-seq analysis reveals BHLHE40-driven pro-tumour neutrophils with hyperactivated glycolysis in pancreatic tumour microenvironment
Liwen Wang, Yihao Liu, Yuting Dai, et al.
Gut (2022) Vol. 72, Iss. 5, pp. 958-971
Open Access | Times Cited: 142
Liwen Wang, Yihao Liu, Yuting Dai, et al.
Gut (2022) Vol. 72, Iss. 5, pp. 958-971
Open Access | Times Cited: 142
Proteogenomic characterization of 2002 human cancers reveals pan-cancer molecular subtypes and associated pathways
Yiqun Zhang, Fengju Chen, Darshan S. Chandrashekar, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 141
Yiqun Zhang, Fengju Chen, Darshan S. Chandrashekar, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 141
Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implications
Qian Zhong, Xina Xiao, Yijie Qiu, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 114
Qian Zhong, Xina Xiao, Yijie Qiu, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 114
Tumor microbiome links cellular programs and immunity in pancreatic cancer
Bassel Ghaddar, Antara Biswas, Chris Harris, et al.
Cancer Cell (2022) Vol. 40, Iss. 10, pp. 1240-1253.e5
Open Access | Times Cited: 98
Bassel Ghaddar, Antara Biswas, Chris Harris, et al.
Cancer Cell (2022) Vol. 40, Iss. 10, pp. 1240-1253.e5
Open Access | Times Cited: 98
NCOA4-Mediated Ferritinophagy Is a Pancreatic Cancer Dependency via Maintenance of Iron Bioavailability for Iron–Sulfur Cluster Proteins
Naiara Santana-Codina, Maria Quiles del Rey, Kevin S. Kapner, et al.
Cancer Discovery (2022) Vol. 12, Iss. 9, pp. 2180-2197
Open Access | Times Cited: 94
Naiara Santana-Codina, Maria Quiles del Rey, Kevin S. Kapner, et al.
Cancer Discovery (2022) Vol. 12, Iss. 9, pp. 2180-2197
Open Access | Times Cited: 94
Tryptophan depletion results in tryptophan-to-phenylalanine substitutants
Abhijeet Pataskar, Julien Champagne, Remco Nagel, et al.
Nature (2022) Vol. 603, Iss. 7902, pp. 721-727
Open Access | Times Cited: 85
Abhijeet Pataskar, Julien Champagne, Remco Nagel, et al.
Nature (2022) Vol. 603, Iss. 7902, pp. 721-727
Open Access | Times Cited: 85
Proteogenomic data and resources for pan-cancer analysis
Yize Li, Yongchao Dou, Felipe da Veiga Leprevost, et al.
Cancer Cell (2023) Vol. 41, Iss. 8, pp. 1397-1406
Open Access | Times Cited: 85
Yize Li, Yongchao Dou, Felipe da Veiga Leprevost, et al.
Cancer Cell (2023) Vol. 41, Iss. 8, pp. 1397-1406
Open Access | Times Cited: 85
Epigenetic regulation during cancer transitions across 11 tumour types
Nadezhda V. Terekhanova, Alla Karpova, Wen-Wei Liang, et al.
Nature (2023) Vol. 623, Iss. 7986, pp. 432-441
Open Access | Times Cited: 81
Nadezhda V. Terekhanova, Alla Karpova, Wen-Wei Liang, et al.
Nature (2023) Vol. 623, Iss. 7986, pp. 432-441
Open Access | Times Cited: 81
Topographic mapping of the glioblastoma proteome reveals a triple-axis model of intra-tumoral heterogeneity
K. H. Brian Lam, Alberto J. León, Weili Hui, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 71
K. H. Brian Lam, Alberto J. León, Weili Hui, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 71
Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulation
Yifat Geffen, Shankara Anand, Yo Akiyama, et al.
Cell (2023) Vol. 186, Iss. 18, pp. 3945-3967.e26
Open Access | Times Cited: 70
Yifat Geffen, Shankara Anand, Yo Akiyama, et al.
Cell (2023) Vol. 186, Iss. 18, pp. 3945-3967.e26
Open Access | Times Cited: 70
Artificial intelligence in pancreatic cancer
Bowen Huang, Haoran Huang, Shuting Zhang, et al.
Theranostics (2022) Vol. 12, Iss. 16, pp. 6931-6954
Open Access | Times Cited: 68
Bowen Huang, Haoran Huang, Shuting Zhang, et al.
Theranostics (2022) Vol. 12, Iss. 16, pp. 6931-6954
Open Access | Times Cited: 68
Proteogenomic characterization of small cell lung cancer identifies biological insights and subtype-specific therapeutic strategies
Qian Liu, Jing Zhang, Chenchen Guo, et al.
Cell (2024) Vol. 187, Iss. 1, pp. 184-203.e28
Open Access | Times Cited: 63
Qian Liu, Jing Zhang, Chenchen Guo, et al.
Cell (2024) Vol. 187, Iss. 1, pp. 184-203.e28
Open Access | Times Cited: 63
Pan-cancer proteogenomics connects oncogenic drivers to functional states
Yize Li, Eduard Porta‐Pardo, Collin Tokheim, et al.
Cell (2023) Vol. 186, Iss. 18, pp. 3921-3944.e25
Open Access | Times Cited: 54
Yize Li, Eduard Porta‐Pardo, Collin Tokheim, et al.
Cell (2023) Vol. 186, Iss. 18, pp. 3921-3944.e25
Open Access | Times Cited: 54
What Can Ribo-Seq, Immunopeptidomics, and Proteomics Tell Us About the Noncanonical Proteome?
John R. Prensner, Jennifer G. Abelin, Leron W. Kok, et al.
Molecular & Cellular Proteomics (2023) Vol. 22, Iss. 9, pp. 100631-100631
Open Access | Times Cited: 45
John R. Prensner, Jennifer G. Abelin, Leron W. Kok, et al.
Molecular & Cellular Proteomics (2023) Vol. 22, Iss. 9, pp. 100631-100631
Open Access | Times Cited: 45
Non-invasive activation of intratumoural gene editing for improved adoptive T-cell therapy in solid tumours
Xiaohong Chen, Shuang Wang, Yuxuan Chen, et al.
Nature Nanotechnology (2023) Vol. 18, Iss. 8, pp. 933-944
Closed Access | Times Cited: 41
Xiaohong Chen, Shuang Wang, Yuxuan Chen, et al.
Nature Nanotechnology (2023) Vol. 18, Iss. 8, pp. 933-944
Closed Access | Times Cited: 41
Pan-cancer proteogenomics characterization of tumor immunity
Francesca Petralia, Weiping Ma, Tomer M. Yaron, et al.
Cell (2024) Vol. 187, Iss. 5, pp. 1255-1277.e27
Open Access | Times Cited: 32
Francesca Petralia, Weiping Ma, Tomer M. Yaron, et al.
Cell (2024) Vol. 187, Iss. 5, pp. 1255-1277.e27
Open Access | Times Cited: 32
The Molecular Twin artificial-intelligence platform integrates multi-omic data to predict outcomes for pancreatic adenocarcinoma patients
Arsen Osipov, Ognjen Nikolic, Arkadiusz Gertych, et al.
Nature Cancer (2024) Vol. 5, Iss. 2, pp. 299-314
Open Access | Times Cited: 29
Arsen Osipov, Ognjen Nikolic, Arkadiusz Gertych, et al.
Nature Cancer (2024) Vol. 5, Iss. 2, pp. 299-314
Open Access | Times Cited: 29
Integrated proteogenomic characterization of glioblastoma evolution
Kyung‐Hee Kim, Simona Migliozzi, Harim Koo, et al.
Cancer Cell (2024) Vol. 42, Iss. 3, pp. 358-377.e8
Closed Access | Times Cited: 25
Kyung‐Hee Kim, Simona Migliozzi, Harim Koo, et al.
Cancer Cell (2024) Vol. 42, Iss. 3, pp. 358-377.e8
Closed Access | Times Cited: 25
Prospective observational study on biomarkers of response in pancreatic ductal adenocarcinoma
Lingxi Jiang, Jiejie Qin, Yuting Dai, et al.
Nature Medicine (2024) Vol. 30, Iss. 3, pp. 749-761
Closed Access | Times Cited: 24
Lingxi Jiang, Jiejie Qin, Yuting Dai, et al.
Nature Medicine (2024) Vol. 30, Iss. 3, pp. 749-761
Closed Access | Times Cited: 24
VISTA promotes the metabolism and differentiation of myeloid-derived suppressor cells by STAT3 and polyamine-dependent mechanisms
Keman Zhang, Amin Zakeri, Tyler J. Alban, et al.
Cell Reports (2024) Vol. 43, Iss. 1, pp. 113661-113661
Open Access | Times Cited: 20
Keman Zhang, Amin Zakeri, Tyler J. Alban, et al.
Cell Reports (2024) Vol. 43, Iss. 1, pp. 113661-113661
Open Access | Times Cited: 20
Instrumentation at the Leading Edge of Proteomics
Trenton M. Peters-Clarke, Joshua J. Coon, Nicholas M. Riley
Analytical Chemistry (2024) Vol. 96, Iss. 20, pp. 7976-8010
Closed Access | Times Cited: 20
Trenton M. Peters-Clarke, Joshua J. Coon, Nicholas M. Riley
Analytical Chemistry (2024) Vol. 96, Iss. 20, pp. 7976-8010
Closed Access | Times Cited: 20
Determining the ERK-regulated phosphoproteome driving KRAS-mutant cancer
Jennifer E. Klomp, J. Nathaniel Diehl, Jeffrey A. Klomp, et al.
Science (2024) Vol. 384, Iss. 6700
Open Access | Times Cited: 20
Jennifer E. Klomp, J. Nathaniel Diehl, Jeffrey A. Klomp, et al.
Science (2024) Vol. 384, Iss. 6700
Open Access | Times Cited: 20
Targeting KRAS: from metabolic regulation to cancer treatment
Yanyan Shi, Huiling Zheng, Tianzhen Wang, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Yanyan Shi, Huiling Zheng, Tianzhen Wang, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 3
